| Common Stock, Shares Authorized |
750,000,000 |
shares |
313% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
58,429,000 |
shares |
616% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$222,036,000 |
USD |
191% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$120,733,000 |
USD |
3.6% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$126,003,000 |
USD |
3.4% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$12,778,000 |
USD |
73% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$19,763,000 |
USD |
24% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$0 |
USD |
-100% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$88,612,000 |
USD |
12% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
|
Q2 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$5,957,000 |
USD |
15% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$686,366,000 |
USD |
1052% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$3,536,000 |
USD |
64% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
|
Q2 2025 |
FY 2025 |